Cidara Therapeutics Inc. (CDTX) is on the roll with an average volume of 493.29K in the recent 3 months – Invest Chronicle

Cidara Therapeutics Inc. (CDTX) is on the roll with an average volume of 493.29K in the recent 3 months

For the readers interested in the stock health of Cidara Therapeutics Inc. (CDTX). It is currently valued at $1.53. When the transactions were called off in the previous session, Stock hit the highs of $1.57, after setting-off with the price of $1.41. Company’s stock value dipped to $1.31 during the trading on the day. When the trading was stopped its value was $1.40.Recently in News on November 22, 2021, Cidara Therapeutics Named A San Diego Metro Area Top Workplace For The Fifth Consecutive Year. Cidara recognized as the top-ranked biotech therapeutics company based on employee feedback. You can read further details here

Cidara Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.1500 on 02/16/21, with the lowest value was $1.3100 for the same time period, recorded on 11/23/21.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Cidara Therapeutics Inc. (CDTX) full year performance was -32.60%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cidara Therapeutics Inc. shares are logging -51.43% during the 52-week period from high price, and 9.29% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.40 and $3.15.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3501057 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Cidara Therapeutics Inc. (CDTX) recorded performance in the market was -23.50%, having the revenues showcasing -29.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 102.71M, as it employees total of 79 workers.

Specialists analysis on Cidara Therapeutics Inc. (CDTX)

During the last month, 4 analysts gave the Cidara Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.8012, with a change in the price was noted -0.49. In a similar fashion, Cidara Therapeutics Inc. posted a movement of -24.26% for the period of last 100 days, recording 469,447 in trading volumes.

>> 7 Top Picks for the Post-Pandemic Economy << 

Trends and Technical analysis: Cidara Therapeutics Inc. (CDTX)

Raw Stochastic average of Cidara Therapeutics Inc. in the period of last 50 days is set at 20.37%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 48.89%. In the last 20 days, the company’s Stochastic %K was 22.77% and its Stochastic %D was recorded 20.80%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -23.50%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -23.88%, alongside a downfall of -32.60% for the period of the last 12 months. The shares increased approximately by -8.93% in the 7-day charts and went down by -0.65% in the period of the last 30 days. Common stock shares were lifted by -29.17% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam